MedTrace Logo

Biomarkers in Patients Undergoing Atrial Fibrillation Ablation

NCT03388333 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2019-06-07

No results posted yet for this study

Summary

The investigators aim to find biomarkers to determine the success of pulmonary vein isolation for the treatment of atrial fibrillation.

Conditions

Interventions

PROCEDURE

Catheter Ablation

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Christian Meyer, Prof. Dr. · Germany Department of Cardiology - Electrophysiology, University Heart Centre

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-07-31
Completion
2019-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03388333 on ClinicalTrials.gov